Navigation Links
Hanger, Inc. Has Record Year In O&P Acquisitions:
Date:12/5/2012

AUSTIN, Texas, Dec. 5, 2012 /PRNewswire/ -- Hanger, Inc. (NYSE: HGR) completed the acquisition of Faith Prosthetic-Orthotic Services, Inc. and SCOPe Orthotics & Prosthetics, Inc.  These two patient care companies are comprised of twenty-two clinics in California and North Carolina and generate annualized revenue of $24.6 million, bringing our total annualized revenue from 2012 acquisitions to $60.2 million.  "We are pleased to welcome SCOPe and Faith and their over 160 dedicated clinicians and staff to the Hanger team," commented President and CEO Vinit K. Asar. "I would also like to thank our talented M&A team and all those who have helped with the closing and integration of all our 2012 acquisitions. Our acquisition pipeline remains strong and we look forward to a successful 2013."

About Hanger – Hanger, Inc., headquartered in Austin, Texas, is the world's premier provider of services and products that enhance human physical capability.  Built on the legacy of James Edward Hanger, the first amputee of the American Civil War, Hanger is steeped in 150 years of clinical excellence and innovation.  Hanger provides orthotic and prosthetic patient care services, distributes O&P devices and components, and provides therapeutic solutions to the broader post-acute market.  Hanger is the largest owner and operator of orthotic and prosthetic patient care centers with in excess of 770 O&P patient care clinics located in 45 states and the District of Columbia.  Hanger, through its subsidiary Southern Prosthetic Supply, Inc., is also the largest distributor of branded and private label O&P devices and components in the United States.  Hanger provides therapeutic solutions through its subsidiaries Innovative Neurotronics and Accelerated Care Plus.  Innovative Neurotronics introduces emerging neuromuscular technologies developed through independent research in a collaborative effort with industry suppliers worldwide.  Accelerated Care Plus is a developer of specialized rehabilitation technologies and the nation's leading provider of evidence-based clinical programs for post-acute rehabilitation serving more than 4,400 long-term care facilities and other sub-acute rehabilitation providers throughout the U.S.  For more information on Hanger, visit www.hanger.com and follow us at www.Facebook.com/HangerNews, www.Twitter.com/HangerNews, and www.YouTube.com/HangerNews.


'/>"/>
SOURCE Hanger, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hanger, Inc. Announces 2012 Year To Date Acquisitions Totaling $35.6 Million Of Annual Net Revenue
2. Hanger, Inc. Reports Earnings of $0.50 Per Diluted Share for the Second Quarter 2012
3. Hanger, Inc. Announces Second Quarter 2012 Earnings Release Conference Call
4. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
5. The Female Health Company Reports Record Fourth Quarter and FY2012 Operating Results
6. Kewaunee Scientific Reports Record Sales for Second Quarter
7. Burlington Coat Factory Completes Another Record Year of Supporting The Leukemia & Lymphoma Society in its Quest to Beat Cancer
8. Groupe Athena, Inc. Reports Record First Quarter Revenues, Adoption Of IFRS Accounting Standard In Anticipation Of Applying For Listing On The NASDAQ Bulletin Board
9. Rochester Medical Reports Record Fourth Quarter and Fiscal Year Results
10. ActiveCare Announces Record Revenue For Quarter Ending June 30, 2012
11. NxStage Reports Record Revenue for the Third Quarter of Fiscal 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... REDWOOD CITY, Calif., Feb. 23, 2017 Nevro Corp. ... innovative evidence-based solutions for the treatment of chronic pain, today ... ended December 31, 2016. 2016 Accomplishment & ... the full year 2016, an increase of 228% as reported, ... million for 2016, an increase of 612% over the prior ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
(Date:2/23/2017)... , Feb. 23, 2017 Regulus ... the discovery and development of innovative medicines targeting microRNAs, ... year 2016 financial results on Thursday, March 2, 2017 ... a conference call and webcast on March 2, 2017 ... and full year 2016 financial results and provide a ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... 26, 2017 , ... IndustryArchive.Org . is announcing a new way for ... will now only pay for B.A.N.T. quality sales leads based on the Sellers decision ... the new reality that B2B buyers are controlling the sales process via the Internet ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... disease (PD) in persons with a specific LRRK2 mutation, according to a study ... Previous studies have provided evidence of a link between pesticides and incidence of ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official ... (ILTM) show in Cannes (France), XO Private has initiated a second print-run of its ... measures almost a metre across when open, weighs in at more than six kilos, ...
(Date:2/24/2017)... ... 24, 2017 , ... The Smart Machine Age is here, and it’s disrupting ... percent of all jobs in the United States may be taken over by technology ... the aggressive know-it-all who steamrolls over colleagues is drawing to a close. Success will ...
(Date:2/24/2017)... Australia (PRWEB) , ... February 24, 2017 , ... The ... AU) offers Erik Schanssema ’s true account of his paramedic experiences. Schanssema describes ... stress disorder and his attempts to overcome them. , Schanssema, initially unsure of ...
Breaking Medicine News(10 mins):